Waters Corporation $WAT Shares Bought by California Public Employees Retirement System

California Public Employees Retirement System lifted its holdings in Waters Corporation (NYSE:WAT) by 4.7% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 105,868 shares of the medical instruments supplier’s stock after buying an additional 4,781 shares during the quarter. California Public Employees Retirement System owned approximately 0.18% of Waters worth $36,952,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of WAT. Tema Etfs LLC raised its stake in Waters by 7.4% during the second quarter. Tema Etfs LLC now owns 3,024 shares of the medical instruments supplier’s stock worth $1,055,000 after acquiring an additional 208 shares during the period. Amundi grew its holdings in shares of Waters by 20.1% during the second quarter. Amundi now owns 341,671 shares of the medical instruments supplier’s stock valued at $120,241,000 after purchasing an additional 57,081 shares during the last quarter. Great Diamond Partners LLC acquired a new stake in shares of Waters during the 2nd quarter worth approximately $801,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Waters by 82.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 386 shares of the medical instruments supplier’s stock worth $135,000 after purchasing an additional 175 shares during the last quarter. Finally, CW Advisors LLC lifted its holdings in shares of Waters by 2.0% in the 2nd quarter. CW Advisors LLC now owns 2,112 shares of the medical instruments supplier’s stock worth $737,000 after purchasing an additional 42 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on WAT shares. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Redburn Partners set a $390.00 price objective on shares of Waters in a research report on Wednesday, October 8th. Rothschild Redb upgraded shares of Waters to a “strong-buy” rating in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company raised their price target on shares of Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Waters presently has an average rating of “Moderate Buy” and an average price target of $390.31.

Waters Price Performance

NYSE WAT opened at $396.39 on Thursday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The firm has a market capitalization of $23.60 billion, a PE ratio of 36.43, a P/E/G ratio of 3.51 and a beta of 1.16. The company’s 50 day simple moving average is $365.78 and its 200 day simple moving average is $333.06. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.08.

Waters (NYSE:WAT) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 36.59% and a net margin of 20.89%.The firm had revenue of $608.55 million during the quarter. As a group, equities research analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.